Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05396599 · ClinicalTrials.gov registry record · NA
A Clinical Study Comparing Postoperative Outcomes Between the TECNIS Intraocular Lens.
A NA study, sponsored by Johnson & Johnson Surgical Vision.
- Terminated
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT05396599: Clinical Trial NA study, sponsored by Johnson & Johnson Surgical Vision.
NCT05396599 is a NA study that was terminated before completion, run by Johnson & Johnson Surgical Vision. The registered enrollment target is 35 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05396599, a NA study, was terminated before completion, sponsored by Johnson & Johnson Surgical Vision.
- TERMINATED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
This is a prospective, multi-center, masked, three-arm, randomized clinical study of the TECNIS Eyhance Toric II IOL (test #1) and TECNIS Synergy Toric II (test #2) compared to the TECNIS Toric 1-Piece IOL (control).
Primary Outcome
The percentage of eyes with rotational stability of the IOL at postoperative 1 month.
Interventions
- DEVICE Model DIU
- DEVICE Model DFW
- DEVICE Model ZCT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2022-06-30 |
| Est. Completion | 2023-04-07 |
| Phase | NA |
Why NCT05396599 stopped before completion
NCT05396599 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 3 interventions - of which Model DIU is the first listed.
NCT05396599 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05396599 about?
NCT05396599 is a clinical study titled "A Clinical Study Comparing Postoperative Outcomes Between the TECNIS Intraocular Lens.". This is a prospective, multi-center, masked, three-arm, randomized clinical study of the TECNIS Eyhance Toric II IOL (test #1) and TECNIS Synergy Toric II (test #2) compared to the TECNIS Toric 1-Piece IOL (control).
What is the current status of trial NCT05396599?
This trial is currently terminated. It is a NA study. The enrollment target is 35 participants. The study started on 2022-06-30. Estimated completion is 2023-04-07.
What interventions are being tested in trial NCT05396599?
The interventions under investigation include: Model DIU (DEVICE), Model DFW (DEVICE), Model ZCT (DEVICE).
Who is sponsoring clinical trial NCT05396599?
This trial is sponsored by Johnson & Johnson Surgical Vision, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05396599's enrollment target sits among peer trials
35 1564th of 2000 higher than 431 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI